145 related articles for article (PubMed ID: 28242170)
1. 3-Phenylalkyl-2H-chromenes and -chromans as novel rhinovirus infection inhibitors.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2017 Apr; 25(7):2074-2083. PubMed ID: 28242170
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antirhinovirus activity of new 3-benzyl chromene and chroman derivatives.
Conti C; Desideri N
Bioorg Med Chem; 2009 May; 17(10):3720-7. PubMed ID: 19398344
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2014 Feb; 22(3):1201-7. PubMed ID: 24360829
[TBL] [Abstract][Full Text] [Related]
5. New 4H-chromen-4-one and 2H-chromene derivatives as anti-picornavirus capsid-binders.
Conti C; Desideri N
Bioorg Med Chem; 2010 Sep; 18(17):6480-8. PubMed ID: 20673722
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
7. Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes.
Patrusheva OS; Zarubaev VV; Shtro AA; Orshanskaya YR; Boldyrev SA; Ilyina IV; Kurbakova SY; Korchagina DV; Volcho KP; Salakhutdinov NF
Bioorg Med Chem; 2016 Nov; 24(21):5158-5161. PubMed ID: 27591012
[TBL] [Abstract][Full Text] [Related]
8. Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders.
Fois B; Bianco G; Sonar VP; Distinto S; Maccioni E; Meleddu R; Melis C; Marras L; Pompei R; Floris C; Caboni P; Cottiglia F
J Nat Prod; 2017 Oct; 80(10):2799-2806. PubMed ID: 29039946
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-rhinovirus activity of 2-styrylchromones.
Desideri N; Conti C; Mastromarino P; Mastropaolo F
Antivir Chem Chemother; 2000 Nov; 11(6):373-81. PubMed ID: 11227995
[TBL] [Abstract][Full Text] [Related]
10. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
Desideri N; Mastromarino P; Conti C
Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors.
Tan S; He F; Kong T; Wu J; Liu Z
Bioorg Med Chem; 2017 Aug; 25(15):4123-4132. PubMed ID: 28629630
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
[TBL] [Abstract][Full Text] [Related]
15. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.
Décor A; Grand-Maître C; Hucke O; O'Meara J; Kuhn C; Constantineau-Forget L; Brochu C; Malenfant E; Bertrand-Laperle M; Bordeleau J; Ghiro E; Pesant M; Fazal G; Gorys V; Little M; Boucher C; Bordeleau S; Turcotte P; Guo T; Garneau M; Spickler C; Gauthier A
Bioorg Med Chem Lett; 2013 Jul; 23(13):3841-7. PubMed ID: 23726345
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-rhinovirus properties of fluoro-substituted flavonoids.
Conti C; Mastromarino P; Goldoni P; Portalone G; Desideri N
Antivir Chem Chemother; 2005; 16(4):267-76. PubMed ID: 16130524
[TBL] [Abstract][Full Text] [Related]
18. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological activity and structure-activity relationship of 4,5-dimethoxybenzene derivatives inhibitor of rhinovirus 14 infection.
Roche M; Lacroix C; Khoumeri O; Franco D; Neyts J; Terme T; Leyssen P; Vanelle P
Eur J Med Chem; 2014 Apr; 76():445-59. PubMed ID: 24602790
[TBL] [Abstract][Full Text] [Related]
20. VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection.
Da Costa L; Roche M; Scheers E; Coluccia A; Neyts J; Terme T; Leyssen P; Silvestri R; Vanelle P
Eur J Med Chem; 2016 Jun; 115():453-62. PubMed ID: 27049678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
